Lawsuit filed for Investors who lost money with shares of Neogen Corporation (NASDAQ: NEOG)

An investor, who purchased shares of Neogen Corporation (NASDAQ: NEOG), filed a lawsuit over alleged violations of Federal Securities Laws by Neogen Corporation in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Neogen Corporation (NASDAQ: NEOG) have certain options and for certain investors are short and strict deadlines running. Deadline: September 16, 2025. NASDAQ: NEOG investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Lansing, MI Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally.
Neogen Corporation (NASDAQ: NEOG) reported that itsTotal Revenue declined from $924.22 million for the 12 months period that ended on May 31, 2024 to $894.66 million for the 12 months period that ended on May 31, 2025, and that its Net Loss over those respective time periods increased from $9.42 million to over $1.06 billion.

On January 10, 2025. Neogen Corporation (NASDAQ: NEOG) revealed that GAAP net income in the second quarter was significantly negative due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition and cut its FY25 revenue and EBITDA guidance. Neogen also revealed that, as of November 30, 2024, the Company had material weaknesses in its internal control over financial reporting.
In its next financial quarter, on April 9, 2025, Neogen Corporation (NASDAQ: NEOG) announced that quarterly revenue fell 3.4% to $221 million due to integration issues and again cut its FY25 guidance and noted that capital expenditures were expected to be $100 million as a result of lowered adjusted EBITDA and a pull-forward of integration-related capital expenditures into FY25. Neogen also announced that CEO Adent would be stepping down.

Finally, on June 4, 2025, Neogen Corporation (NASDAQ: NEOG) revealed that it expected "EBITDA margin to probably be around the high-teens" which represented a considerable drop from the previous quarter's profit margin of 22%.

Shares of Neogen Corporation (NASDAQ: NEOG) declined from $23.87 per share on August 16, 2023, to as low as $4.53 per share on June 4, 2025.

The plaintiff claims that between January 5, 2023 through June 3, 2025, the Defendants misrepresented the status of the 3M integration and failed to disclose the negative impact of integration issues on the financial health of Neogen, that the defendants issued a series of materially false and misleading statements which led investors to believe that the integration was progressing smoothly, and that the defendants downplayed integration "inefficiencies" and assured investors that they were fully aware and committed to resolving the issues quickly.

Those who purchased shares of Neogen Corporation (NASDAQ: NEOG) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.